Qiuhua Luo

department of pharmacy

H指数:19

被引数:1,428

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

G6PD+CSV+ circulating tumor cells associated with portal vein tumor thrombus formation via EMT-ferroptosis crosstalk: a dual biomarker for therapeutic efficacy and prognosis prediction in hepatocellular carcinoma

G6PD+CSV+循环肿瘤细胞通过EMT-ferroptosis串扰与门静脉瘤栓形成相关：肝细胞癌中用于疗效评估和预后预测的双标志物

Cancer Letters

IF10.1

2025-12-040

PRE

Chimeric exosomes-derived immunomodulator restoring lymph nodes microenvironment for sensitizing TNBC immunotherapy

嵌合外泌体衍生的免疫调节剂恢复淋巴结微环境以增强TNBC免疫治疗敏感性

Nature Communications

IF15.7

2025-08-020

OAAI

Prognostic and predictive factors in advanced upper gastrointestinal cancer treated with immune checkpoint inhibitors: a systematic review and meta-analysis of the current evidence

BMC CANCER

IF3.4

2024-10-090

OAAI

Lyophilized lymph nodes: A paradigm shift in CAR T-cell delivery for solid tumor therapy

ACTA PHARMACEUTICA SINICA B

IF14.6

2024-08-010

OAAI

A disulfiram/copper gluconate co-loaded bi-layered long-term drug delivery system for intraperitoneal treatment of peritoneal carcinomatosis

COLLOIDS AND SURFACES B-BIOINTERFACES

IF5.6

2023-11-014

PRE

A boronic acid conjugation integrates antitumor drugs into albumin-binding prodrugs-based nanoparticles with robust efficiency for cancer therapy

NANO RESEARCH

IF9

2023-02-272

PRE

Chiral Nanosilica Drug Delivery Systems Stereoselectively Interacted with the Intestinal Mucosa to Improve the Oral Adsorption of Insoluble Drugs

手性纳米二氧化硅药物递送系统与肠粘膜立体选择性相互作用，以改善难溶性药物的口服吸附

ACS NANO

IF16

2023-02-1422

PRE

Nano-ROS-generating approaches to cancer dynamic therapy: Lessons from nanoparticles

癌症动态治疗的纳米ROS生成方法: 纳米颗粒的经验教训

CHEMICAL ENGINEERING JOURNAL

IF13.2

2023-02-0144

PRE

Immunogenic Nanovesicle-Tandem-Augmented Chemoimmunotherapy via Efficient Cancer-Homing Delivery and Optimized Ordinal-Interval Regime

ADVANCED SCIENCE

IF14.1

2022-12-0115

Multi-functional extracellular vesicles: Potentials in cancer immunotherapy

CANCER LETTERS

IF10.1

2022-12-014

PRE

Recent advances in bacteriophage-based therapeutics: Insight into the post-antibiotic era

ACTA PHARMACEUTICA SINICA B

IF14.6

2022-12-0151

OAAI

Hydrochlorothiazide/Losartan Potassium Tablet Prepared by Direct Compression

PHARMACEUTICS

IF5.5

2022-08-2112

OAAI

MORC protein family-related signature within human disease and cancer

CELL DEATH & DISEASE

IF9.6

2021-11-2719

OAAI

Tumor Microenvironment-Responsive Shell/Core Composite Nanoparticles for Enhanced Stability and Antitumor Efficiency Based on a pH-Triggered Charge-Reversal Mechanism

PHARMACEUTICS

IF5.5

2021-06-166

OAAI

Pharmaceutical strategies in improving anti-tumour efficacy and safety of intraperitoneal therapy for peritoneal metastasis

EXPERT OPINION ON DRUG DELIVERY

IF5.4

2021-03-101

PREAI

Risk of Gastrointestinal Adverse Events in Cancer Patients Treated With Immune Checkpoint Inhibitor Plus Chemotherapy: A Systematic Review and Meta-Analysis

免疫检查点抑制剂联合化疗治疗癌症患者胃肠道不良事件风险的系统评价和Meta分析

FRONTIERS IN ONCOLOGY

IF3.3

2020-03-109

OAAI

Amino acid transporters: Emerging roles in drug delivery for tumor-targeting therapy

氨基酸转运蛋白: 在肿瘤靶向治疗药物递送中的新兴作用

ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES

IF11.9

2020-03-0133

OAAI

Endocytosis of ATB0,+(SLC6A14)-targeted liposomes for drug delivery and its therapeutic application for pancreatic cancer

EXPERT OPINION ON DRUG DELIVERY

IF5.4

2020-02-0527

PREAI

Laccase-Carbon nanotube nanocomposites for enhancing dyes removal

JOURNAL OF CLEANER PRODUCTION

IF10

2020-01-0163

PREAI

Amygdala Changes in Chronic Insomnia and Their Association with Sleep and Anxiety Symptoms: Insight from Shape Analysis

NEURAL PLASTICITY

IF3.7

2019-12-0144

OAAI

Qiuhua Luo

个人简介

教育背景

工作经历

荣誉奖项

研究方向